发明名称 MicroRNA compounds and methods for modulating miR-21 activity
摘要 Described herein are compositions and methods for the inhibition of miR-21 activity. The compositions have certain nucleoside modification patterns that yield potent inhibitors of miR-21 activity. The compositions may be used to inhibit miR-21, and also to treat diseases associated with abnormal expression of miR-21, such as fibrosis and cancer.
申请公布号 US9267137(B2) 申请公布日期 2016.02.23
申请号 US201514597676 申请日期 2015.01.15
申请人 Regulus Therapeutics Inc. 发明人 Bhat Balkrishen;Marcusson Eric
分类号 C12N15/11;C07H19/00;C12N15/113;A61K31/712;A61K45/06 主分类号 C12N15/11
代理机构 McNeill Baur PLLC 代理人 McNeill Baur PLLC
主权项 1. A compound comprising a modified oligonucleotide consisting of 12, 13, 14, or 15 linked nucleosides, wherein the nucleobase sequence of the modified oligonucleotide is complementary to miR-21 (SEQ ID NO: 1) and wherein the modified oligonucleotide comprises at least 12 contiguous nucleosides of the following nucleoside pattern VI in the 5′ to 3′ orientation: NQ—NB—NB—NQ—(NB—NB—NQ—NQ)2—NB—NQ—NB wherein each NQ is a non-bicyclic nucleoside; and each NB is a bicyclic nucleoside.
地址 San Diego CA US